Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.21
+0.16 (1.59%)
Mar 9, 2026, 1:22 PM EDT - Market open
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $581.60 million as of March 9, 2026. Its market cap has increased by 105.03% in one year.
Market Cap
581.60M
Enterprise Value
376.23M
1-Year Change
105.03%
Ranking
Category
Stock Price
$10.21
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $581.60M, a decrease of -73.64%. That is a compound annual growth rate of -23.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 572.49M | 7.14% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 601.61M |
| enGene Holdings | 581.47M |
| YD Bio | 573.10M |
| Larimar Therapeutics | 566.84M |
| MeiraGTx Holdings | 563.44M |
| Verastem | 560.39M |
| Alpha Tau Medical | 546.54M |
| Fulcrum Therapeutics | 544.12M |